Shilpa Medicare Limited
Shilpa Medicare Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: SHILPAMED and BSE: 530549 (ISIN INE790G01031).
It has a market capitalisation of ₹17,138 crore, a last close of ₹876.20 on 2026-10-19, a one-year return of 146.1%.
Valuation: a price-to-earnings ratio of 57.64x, a price-to-book ratio of 6.61x, a dividend yield of 0.1%.
Profitability: return on equity of 9.8%, return on capital employed of 12.9%, an operating margin of 28.4%.
Growth: sales growth of 13.6% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.25x, promoter holding of 40.1%.
| Metric | Value |
|---|---|
| Market capitalisation | 17,138 |
| Last close | ₹876.20 |
| P/E (TTM) | 57.64x |
| P/B | 6.61x |
| Dividend yield | 0.1% |
| ROE (FY) | 9.8% |
| ROCE (FY) | 12.9% |
| Operating margin (TTM) | 28.4% |
| Sales growth, 3-year CAGR | 13.6% |
| Debt / equity | 0.25x |
| Promoter holding | 40.1% |
| 1-year return | 146.1% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means